Antibodies elicited by N2,N2-7-trimethylguanosine react with small nuclear RNAs and ribonucleoproteins.
The 5' ends of U1, U2, U3, U4, and U5 small nuclear RNAs (snRNA) are capped by a structure which contains N2,N2-7-trimethylguanosine (m2,2,7 G). m2,2,7 G was used as hapten to raise antibodies in rabbits, and these antibodies were linked to Sepharose. When deproteinized RNA was passed through this antibody column, these snRNA species were retained by the column. Conversely, 4 S, 5 S, 5.8 S, U6, and 7 S RNA, whose 5' termini do not contain m2,2,7 G, were not recognized. After a nuclear extract was loaded on the column, U1 RNA and some U2 RNA were retained. Therefore, the 5' ends of at least U1 RNA are accessible when this RNA species is in small nuclear ribonucleoprotein particle (snRNP) form. This is of interest, since it has been proposed that the 5' terminus sequence of U1 RNA may hybridize with splice junctions in heterogeneous nuclear ribonucleoprotein particles (hnRNP) during mRNA splicing. The retention of m2,2,7 G-containing RNA species by these antibodies is not due to association of snRNAs or snRNPs with heterogeneous nuclear RNA (hnRNA) or hnRNP (and antibody recognition of 7-monomethylguanosine residues in hnRNA), since the reaction still occurs after removal of hnRNA or hnRNP by sucrose gradient centrifugation.
D000906:Antibodies; D000936:Antigen-Antibody Complex; D002277:Carcinoma; D002460:Cell Line; D000939:Epitopes; D006151:Guanosine / Q000031:analogs & derivatives* / Q000276:immunology; D006801:Humans; D005779:Immunodiffusion; D009062:Mouth Neoplasms; D009698:Nucleoproteins / Q000276:immunology*; D012313:RNA / Q000276:immunology*; D012342:RNA, Small Nuclear; D012261:Ribonucleoproteins / Q000276:immunology*; D013056:Spectrophotometry, Ultraviolet
D000906:Antibodies; D000936:Antigen-Antibody Complex; D000939:Epitopes; D009698:Nucleoproteins; D012342:RNA, Small Nuclear; D012261:Ribonucleoproteins; D006151:Guanosine; C017778:N(2),N(2),7-trimethylguanosine; D012313:RNA